Medicare Price Negotiation: Special Treatment For ‘Novel Technologies’ On PhRMA’s Advocacy Agenda

 
• By Cathy Kelly
  
'9/13' Issue Is Highest IRA Priority For Industry • Source: Shutterstock

More from Market Access

More from Pink Sheet